This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Britney L Ragunton
Introduction
Britney L Ragunton is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of cell culture monitoring through her innovative patent. Her work is particularly relevant in the context of improving the quality of cell treatments in various applications.
Latest Patents
Britney holds a patent for an "Imaging-based system for monitoring quality of cells in culture." This invention describes techniques to regulate the treatment of a culture of cells that correspond to different cell categories. The system includes an imaging sensor that captures images of the culture and an incubator designed to maintain optimal conditions for the cells. The treatment regulation is based on processing the images obtained, which involves segmenting the images into multiple segments corresponding to different cell categories. This innovative approach allows for precise determination of the amount of culture related to specific cell categories, thereby informing treatment regulation.
Career Highlights
Britney is currently employed at Amgen Inc., a leading biotechnology company. Her role involves applying her expertise in cell culture and imaging technologies to advance research and development in the field. With her innovative mindset, she has contributed to the company's mission of improving patient outcomes through biotechnology.
Collaborations
Throughout her career, Britney has collaborated with talented individuals such as Stuart Chambers and Devin Wakefield. These collaborations have fostered a creative environment that encourages the exchange of ideas and enhances the development of innovative solutions.
Conclusion
Britney L Ragunton's contributions to the field of cell culture monitoring exemplify the impact of innovation in biotechnology. Her patent and work at Amgen Inc. highlight her commitment to advancing scientific research and improving treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
